Enoxaparin superior to warfarin in prevention of venous thromboembolism after primary TKA .
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
Prevention of venous thromboembolic disease following primary total knee arthroplasty. A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin
J Bone Joint Surg Am. 2001 Jun;83-A(6):900-6349 patients undergoing knee arthroplasty were randomized to receive thromboprophylaxis with enoxaparin or warfarin postoperatively. Patients were assessed for venous thromboembolism defined as deep vein thrombosis and pulmonary vein thrombosis. Enoxaparin was significantly more effective than adjusted‐dose warfarin in reducing the occurrence of asymptomatic venous thromboembolism, including proximal deep‐vein thrombosis, in patients undergoing total knee arthroplasty. Overall hemorrhagic complications occurred at a significantly higher rate in the enoxaparin group, but with no significant difference for major events.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
